A detailed history of Capital International Investors transactions in Novo Nordisk A S stock. As of the latest transaction made, Capital International Investors holds 7,085,333 shares of NVO stock, worth $959 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
7,085,333
Previous 7,114,931 0.42%
Holding current value
$959 Million
Previous $736 Million 23.6%
% of portfolio
0.19%
Previous 0.17%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $3.02 Million - $4.02 Million
-29,598 Reduced 0.42%
7,085,333 $910 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $114 Million - $137 Million
1,297,536 Added 22.3%
7,114,931 $736 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $213 Million - $467 Million
2,342,009 Added 67.39%
5,817,395 $529 Million
Q2 2023

Aug 11, 2023

SELL
$155.98 - $172.65 $31.9 Million - $35.3 Million
-204,313 Reduced 5.55%
3,475,386 $562 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $336 Million - $404 Million
-2,540,876 Reduced 40.85%
3,679,699 $586 Million
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $6.08 Million - $8.02 Million
-59,284 Reduced 0.94%
6,220,575 $842 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $5.53 Million - $6.79 Million
58,068 Added 0.93%
6,279,859 $628 Million
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $92.5 Million - $109 Million
896,241 Added 16.83%
6,221,791 $689 Million
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $30.5 Million - $36.9 Million
-327,493 Reduced 5.79%
5,325,550 $596 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $17.2 Million - $21 Million
179,049 Added 3.27%
5,653,043 $631 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $11.1 Million - $14 Million
131,106 Added 2.45%
5,473,994 $526 Million
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $18.3 Million - $22.9 Million
270,517 Added 5.33%
5,342,888 $448 Million
Q1 2021

May 14, 2021

BUY
$67.06 - $75.82 $23.7 Million - $26.8 Million
353,783 Added 7.5%
5,072,371 $343 Million
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $8.74 Million - $10.1 Million
136,767 Added 2.98%
4,718,588 $330 Million
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $12.5 Million - $13.8 Million
-195,993 Reduced 4.1%
4,581,821 $320 Million
Q2 2020

Aug 14, 2020

BUY
$58.54 - $67.94 $152 Million - $177 Million
2,601,458 Added 119.53%
4,777,814 $313 Million
Q1 2020

May 15, 2020

BUY
$49.46 - $64.78 $13.9 Million - $18.2 Million
281,520 Added 14.86%
2,176,356 $131 Million
Q4 2019

Feb 18, 2020

BUY
$49.86 - $58.26 $27.8 Million - $32.5 Million
558,446 Added 41.79%
1,894,836 $110 Million
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $24.8 Million - $27.8 Million
520,897 Added 63.88%
1,336,390 $69.1 Million
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $27,138 - $30,432
580 Added 0.07%
815,493 $41.6 Million
Q4 2018

Feb 14, 2019

SELL
$41.54 - $47.25 $83 - $94
-2 Reduced -0.0%
814,913 $37.5 Million
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $17 Million - $18.6 Million
363,500 Added 80.52%
814,915 $38.4 Million
Q1 2018

May 15, 2018

BUY
$48.49 - $58.14 $48 - $58
1 Added 0.0%
451,415 $22.2 Million
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $18.6 Million - $22.2 Million
451,414
451,414 $21.7 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $305B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.